Upstream Bio (UPB) Stock Insights

UPB price $2.98 +0.19 +6.81%

Ticker
UPB
Price
$2.98
Change
+0.19 +6.81%
Market cap ?
$163.22M
Beta ?
1.39
Sector
Healthcare
Industry
Biotechnology

Fair value

UPB fair value Not meaningful. Price $2.98.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare UPB

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—-0.73—522.46K
2026-08-11-0.73-0.78773.00K431.14K
2026-05-13-0.75-0.751.03M1.03M
2026-03-26-0.79-0.73668.00K584.00K
2025-11-05-0.63-0.78683.00K521.57K
2025-08-06-0.74-0.61937.00K317.00K
2025-05-06-0.51-0.49566.00K317.00K
2025-03-12-0.41-0.56613.00K384.77K
2024-11-07-6.96-0.54607.00K397.25K
2024-10-11————
2023-12-31-0.14—2.38M—
2023-09-30-0.09—621.00K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-16GRAY MICHAELSell853$5.494.68K
2026-09-16Ambrose AllisonSell485$5.492.66K
2026-09-16Deykin AaronSell895$5.494.91K
2026-09-16Sutherland Everett RandSell2.10K$5.4911.50K
2026-09-16Houghton AdamSell700$5.493.84K
2026-06-16GRAY MICHAELSell853$6.105.20K
2026-06-16Sutherland Everett RandSell2.10K$6.1012.78K
2026-06-16Houghton AdamSell700$6.104.27K
2026-06-16Deykin AaronSell895$6.105.46K
2026-06-16Ambrose AllisonSell477$6.102.91K
2026-06-09Ruddy Marcella K.Buy17.10K$6.69114.37K
2026-06-09Renaud Ronald C JRBuy17.10K$6.69114.37K
2026-06-09Fleming Harold EdwardBuy17.10K$6.69114.37K
2026-06-09Beckman DaniellaBuy17.10K$6.69114.37K
2026-06-09Ratcliffe LiamBuy17.10K$6.69114.37K
2026-06-09Chimovits ErezBuy17.10K$6.69114.37K
2026-03-16GRAY MICHAELSell852$9.297.92K
2026-03-16Deykin AaronSell894$9.298.31K
2026-03-16Sutherland Everett RandSell2.09K$9.2919.44K
2026-03-16Ambrose AllisonSell475$9.294.41K
2026-03-16Houghton AdamSell699$9.296.49K
2026-01-02GRAY MICHAELBuy91.50K$27.072.48M
2026-01-02GRAY MICHAELBuy30.50K——
2026-01-02Deykin AaronBuy96.00K$27.072.60M
2026-01-02Deykin AaronBuy32.00K——
2026-01-02Ambrose AllisonBuy51.00K$27.071.38M
2026-01-02Ambrose AllisonBuy17.00K——
2026-01-02Houghton AdamBuy75.00K$27.072.03M
2026-01-02Houghton AdamBuy25.00K——
2026-01-02Sutherland Everett RandBuy225.00K$27.076.09M
2026-01-02Sutherland Everett RandBuy75.00K——
2025-06-10Renaud Ronald C JRBuy17.10K$11.59198.14K
2025-06-10Chimovits ErezBuy17.10K$11.59198.14K
2025-06-10Ruddy Marcella K.Buy17.10K$11.59198.14K
2025-06-10Beckman DaniellaBuy17.10K$11.59198.14K
2025-06-10Fleming Harold EdwardBuy17.10K$11.59198.14K
2025-06-10Ratcliffe LiamBuy17.10K$11.59198.14K
2025-02-06Sutherland Everett RandBuy500.00K$8.534.26M
2025-02-06GRAY MICHAELBuy195.00K$8.531.66M
2025-02-06Houghton AdamBuy140.00K$8.531.19M
2025-02-06Deykin AaronBuy165.00K$8.531.41M
2025-02-06Ambrose AllisonBuy25.00K$8.53213.25K
2024-12-16Ambrose AllisonBuy100.00K$19.011.90M
2024-12-16Ambrose AllisonOther0——
2024-10-15Chimovits ErezBuy660.00K$17.0011.22M
2024-10-15Chimovits ErezBuy2.89M——
2024-10-15Chimovits ErezBuy165.00K$17.002.81M
2024-10-15Chimovits ErezBuy721.96K——
2024-10-15Chimovits ErezSell2.10M——
2024-10-15Chimovits ErezSell789.83K——
2024-10-15ORBIMED ADVISORS LLCBuy660.00K$17.0011.22M
2024-10-15ORBIMED ADVISORS LLCBuy2.89M——
2024-10-15ORBIMED ADVISORS LLCBuy165.00K$17.002.81M
2024-10-15ORBIMED ADVISORS LLCBuy721.96K——
2024-10-15ORBIMED ADVISORS LLCSell2.10M——
2024-10-15ORBIMED ADVISORS LLCSell789.83K——
2024-10-15AI Upstream LLCBuy1.17M——
2024-10-15AI Upstream LLCBuy3.15M——
2024-10-15AI Upstream LLCBuy1.18M$17.0019.98M
2024-10-15AI Upstream LLCSell3.15M——
2024-10-15AI Upstream LLCSell1.17M——
2024-10-15Wellington Biomedical Innovation Master Investors (Cayman) II L.P.Buy894.73K——
2024-10-15Wellington Biomedical Innovation Master Investors (Cayman) II L.P.Sell852.94K——
2024-10-10Chimovits ErezBuy17.10K$17.00290.63K
2024-10-10Ruddy Marcella K.Buy17.10K$17.00290.63K
2024-10-10Renaud Ronald C JRBuy17.10K$17.00290.63K
2024-10-10Fleming Harold EdwardBuy17.10K$17.00290.63K
2024-10-10Beckman DaniellaBuy34.68K$17.00589.58K
2024-10-10Ratcliffe LiamBuy17.10K$17.00290.63K
2024-10-10Wellington Biomedical Innovation Master Investors (Cayman) II L.P.Other894.73K——
2024-10-10Sutherland Everett RandOther866.70K$5.694.93M
2024-10-10Sutherland Everett RandOther1.05M$6.596.94M
2024-10-10Chimovits ErezOther0——
2024-10-10Chimovits ErezOther0——
2024-10-10Chimovits ErezOther2.10M——
2024-10-10Chimovits ErezOther789.83K——
2024-10-10Beckman DaniellaOther0——
2024-10-10Houghton AdamOther134.14K$3.45462.78K
2024-10-10Houghton AdamOther11.95K$4.2751.04K
2024-10-10Houghton AdamOther11.85K$4.8757.72K
2024-10-10Houghton AdamOther62.94K$6.59414.77K
2024-10-10Ruddy Marcella K.Other13.16K$3.4545.40K
2024-10-10Ruddy Marcella K.Other43.12K$4.27184.10K
2024-10-10Ruddy Marcella K.Other7.87K$4.8738.31K
2024-10-10Ratcliffe LiamOther0——
2024-10-10Deykin AaronOther182.43K$3.45629.39K
2024-10-10Deykin AaronOther16.26K$4.2769.42K
2024-10-10Deykin AaronOther11.85K$4.8757.72K
2024-10-10Deykin AaronOther107.21K$6.59706.49K
2024-10-10Fleming Harold EdwardOther0——
2024-10-10ORBIMED ADVISORS LLCOther0——
2024-10-10ORBIMED ADVISORS LLCOther0——
2024-10-10ORBIMED ADVISORS LLCOther2.10M——
2024-10-10ORBIMED ADVISORS LLCOther789.83K——
2024-10-10Renaud Ronald C JROther107.31K$3.45370.23K
2024-10-10Renaud Ronald C JROther9.56K$4.2740.83K
2024-10-10Renaud Ronald C JROther31.47K$4.87153.26K
2024-10-10Renaud Ronald C JROther113.55K$6.59748.32K
2024-10-10GRAY MICHAELOther152.45K$5.69867.44K
2024-10-10AI Upstream LLCOther3.00M——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 153, holders +8 vs prior quarter. Ownership 93.17%.

HolderSharesChangeChange %Value
FMR LLC8.16M61.33K+0.76%56.49M
ORBIMED ADVISORS LLC5.69M00.00%39.40M
NORGES BANK3.77M3.77MNew26.08M
BLACKROCK, INC.3.75M382.67K+11.35%25.97M
DECHENG CAPITAL LLC2.72M00.00%18.86M
ENAVATE SCIENCES GP, LLC2.46M00.00%17.02M
VANGUARD CAPITAL MANAGEMENT LLC1.88M3.16K+0.17%12.99M
MILLENNIUM MANAGEMENT LLC1.14M206.45K+22.03%7.91M
D. E. SHAW & CO., INC.1.04M215.56K+26.27%7.17M
JPMORGAN CHASE & CO1.01M549.04K+118.58%7.01M
QUBE RESEARCH & TECHNOLOGIES LTD978.50K359.18K+58.00%6.77M
PARKMAN HEALTHCARE PARTNERS LLC935.25K148.46K+18.87%6.47M
GEODE CAPITAL MANAGEMENT, LLC931.26K-19.36K-2.04%6.45M
SEB ASSET MANAGEMENT AB878.47K00.00%6.08M
WOODLINE PARTNERS LP831.48K00.00%5.75M
STATE STREET CORP766.32K60.97K+8.64%5.30M
VANGUARD PORTFOLIO MANAGEMENT LLC712.67K-15.04K-2.07%4.93M
Y-INTERCEPT (HONG KONG) LTD693.55K-307.08K-30.69%4.80M
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC600.95K-266.26K-30.70%4.16M
AQR CAPITAL MANAGEMENT LLC544.87K472.70K+654.97%3.77M
MORGAN STANLEY524.63K-27.98K-5.06%3.63M
BNP PARIBAS FINANCIAL MARKETS511.55K385.55K+305.99%3.54M
WALLEYE CAPITAL LLC498.49K498.49KNew3.45M
TREXQUANT INVESTMENT LP466.43K289.77K+164.03%3.23M
POINT72 ASSET MANAGEMENT, L.P.453.01K441.51K+3839.23%3.13M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Upstream Bio (UPB) Stock Insights

UPB$2.98+0.19 +6.81%

$163.22M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History